anti-proliferative activity against human cervical cancer (HeLa), human colon cancer (HT29), rat glioma (C6) and African green monkey kidney (Vero) cell lines. The DNA/BSA binding affinities of these compounds were also elucidated by spectroscopic titrations, displacement experiments, and electrophoresis measurements. Studies on cancerous cells revealed that C1, C2, C4 and C6 have exhibited the significant antitumor activity and inhibited tumor progression during testing cell lines and showed high solubility in the solvent. The results of absorbance and emission spectra data have revealed that the complexes interact with the DNA via groove binding mode of interaction. Overall, these compounds have been found to demonstrate effective antiproliferative activity against the cancer cell lines, indicating that they are a potent candidate for preclinical or clinical studies.
anti-proliferative activity against human cervical cancer (HeLa), human colon cancer (HT29), rat glioma (C6) and African green monkey kidney (Vero) cell lines. The DNA/BSA binding affinities of these compounds were also elucidated by spectroscopic titrations, displacement experiments, and electrophoresis measurements. Studies on cancerous cells revealed that C1, C2, C4 and C6 have exhibited the significant antitumor activity and inhibited tumor progression during testing cell lines and showed high solubility in the solvent. The results of absorbance and emission spectra data have revealed that the complexes interact with the DNA via groove binding mode of interaction. Overall, these compounds have been found to demonstrate effective antiproliferative activity against the cancer cell lines, indicating that they are a potent candidate for preclinical or clinical studies. Developing countries especially suffer from the burden of cancer incidence, morbidity, and mortality [1] . Efforts to reduce the economic burden caused due to the cancer on individuals, families and the healthcare system will increase [1] . Research efforts on the development of novel anticancer agents play an important role in the current treatment process for cancer. These investigations are focused on the goal to find effective drugs without side effects or drug resistance [2] [3] [4] [5] [6] [7] . It is known that the metal complexes including copper, gold, germanium, iron, that has a vital role in the normal functioning of the nervous system. Palladium is a metal with low toxicity and is like platinum. It is a component of cis-platin, which is an anticancer drug.
INTRODUCTION
Nickel, zinc, cobalt and palladium complexes have also shown DNA binding capacity and antiproliferative activity [11] [12] [13] [14] [15] . However, metal complex of cyanido and N-bishydeten (N,N-bis(2-hydroxyethyl)-ethylenediamine) ligands have not been explored in terms of their chemical and chemotherapeutic usage. Our work in this area was concentrated on the use of these ligands to form C1-C6 compounds and test their activities against colon, cervix and glioma cancer.
Korkmaz et al. [16] [17] [18] have explored the Ni II and Zn II metal ions with a capping ligand N,Nbishydeten. The in vitro biological activity of the metal complexes was estimated using the ELISA BrdU cell proliferation assay (CPA) and Lactate Dehydrogenase (LDH) cytotoxicity assay against the cancer cell lines HT29, HeLa, C6, and Vero. The morphology of cells was investigated using phase-contrast microscopy. These complexes have also been studied to determine the extent of their physicochemical properties regarding DNA/BSA binding, and inhibition of restriction in the endonucleases activity features. The interaction of these compounds with DNA/BSA is a significant property in the determination of the mechanisms of compounds because DNA/BSA is a significant chemotherapeutic target for many current anticancer agents. According to the present literature, this is the first study investigating the biological activities of the N-bishydeten based complexes. 
MATERIALS and METHODS

Materials
Synthesis of C1-C6
In our previous studies, we have reported the synthesis and characteristic properties of C1-C6
coordination compounds [16] [17] [18] . These compounds were synthesized according to the procedure published before. The procedure is based on brick-and-mortar method. 
Cell culture
The anticancer potential of these complexes was investigated on cancerous HT29 (ATCC ® HTB- complexes at 37°C with 5% CO2 for overnight. Cell proliferation assay was analyzed using ELISA BrdU methods as described previously [7] .
Calculation of IC50 and percent inhibition
IC50 value is a concentration value at which half of the cells are inhibited in vitro. The half maximal inhibitory concentrations (IC50) of the test and control compounds were calculated using XLfit5® or Microsoft Excel® spreadsheet and represented in µM at 95% confidence intervals. The proliferation assay results were expressed as the percent inhibition according to the following formula:
Cytotoxic activity assay
The cytotoxicity of the compounds and cis-platin was determined on HeLa, C6, HT29, and Vero cells through a Lactate Dehydrogenase Assay Kit according to the instruction given by manufacturer. Approximately 5 x 10 3 cells in 100 µL were placed in 96-well plate as triplicates and treated with IC50 (µg/mL) concentrations of test compounds at 37°C under 5% CO2
atmosphere for 24 h. LDH activity was obtained at 492 -630 nm absorbance wavelength using a microplate reader.
Cell imaging
Cells were plated in 96-well plate at a density of 5000 cells per well and allowed 24 h incubation.
IC50 values of the test compounds were administered and morphology changes of the cells were screened via phase contrast microscopy every 6 h for 24 h. Images of control and test compound-treated cells were photographed at the end of the process using a digital camera attached on inverted microscope.
DNA/BSA binding and gel electrophoresis studies
The binding constants ‫)ܾܭ(‬ and the interaction of the compounds with Calf thymus-DNA (CT-DNA) were examined using the UV spectrophotometry. A CT-DNA solution was prepared by dissolving 2.5 mg of CT-DNA in 10.0 mL of Tris-HCl buffer and it was used immediately after it was prepared. The concentration of CT-DNA was determined spectrophotometrically with the aid of Ɛ value of 6600 M −1 cm −1 at 260 nm. After dissolving the CT-DNA fibers in Tris-HCl buffer, the purity of this solution was checked through the absorbance ratio of A260/A280. The DNA was pure enough to use with respect to the result A260/A280 ratio of 1.83 obtained for the CT-DNA solution in the buffer. These compounds dissolved in DMSO were re-diluted with Tris-HCl buffer to obtain the concentration of 25 µM. Test compounds in the solutions were incubated with CT-DNA solution at 20°C for about 30 min before measurements. The UV absorption spectra data were obtained without any change on the concentrations of both compounds with increasing the CT-DNA concentrations (0-100 μM). Absorption spectra were recorded using 1-cm-path quartz cuvettes at room temperature [19] .
To evaluate the interaction of the compounds with BSA, a UV spectrophotometer was used. A solution of BSA was prepared by dissolving 2.5 mg BSA in 10.0 mL in Tris-HCl buffer and it was used immediately after it was prepared. The UV wavelength scans of the BSA solutions (0-100 μM) with a fixed concentration of the complexes (25 μM) were screened in the wavelength range of 250-320 nm.
The restriction on enzyme inhibition assay was conducted to determine the both specific and nonspecific binding and enzyme inhibition by the complexes. These complexes (25 μM) were added to reaction tubes containing supercoiled pTOLT (10 μM) plasmid DNA, and restriction enzymes KpnI and BamHI (2 units) in Tris-HCl/NaCl buffer (50/18 mM, pH 7.2) and incubated at 37 °C for 4 h. The digestion products were observed by using 1.5% (wt/vol) agarose gel with ethidium bromide.
Statistical analysis
The statistical significance of differences was determined through one-way analysis of variance (one-way ANOVA) tests. Post hoc analyses of group differences were performed using the Tukey test, and the levels of probability were noted. The SPSS® software for Windows was used for the statistical analyses. The results are reported as the mean values ± SEM of three independent assays, and the differences between groups were regarded as significant at P < 0.05.
RESULTS and DISCUSSION
FT-IR Spectra
In the FT-IR spectra of the C1-C6 compounds, absorption bands arising from all characteristic functional groups of the N-bishydeten ligand (υOH and υNH2, υCH2, δNH2, δCH2, υC-N and υCO)
vibrations were observed (Figure 1 ). Also, Figure 1 exhibits various characteristic absorption bands that confirm the presence of the N,N-bishydeten ligand, which coordinates to the metal centers via its NH2 and OH groups. The tentative assignments of the recorded wavenumbers of the C1-C6 compounds are in good agreement with the FT-IR spectra of the compounds synthesized and characterized in our previous studies [16] [17] [18] . 
Anti-proliferative effects of the complexes against HT29, HeLa, C6 and Vero cells
We firstly studied the in vitro anti-proliferative effects of six compounds using ELISA BrdU assay against three cancer cell lines (HT29, HeLa, and C6) and one non-cancerous cell line, namely
Vero. The cis-platin, an anticancer drug, was used as a reference compound. The data obtained using the ELISA BrdU assay, % inhibition data of the compounds was shown in Figure 2 . IC50 values to be used in subsequent studies were calculated by XLfit 5 software and available in Table 1 . Tumor specificity information was obtained by dividing the sum of the IC50 values obtained from the normal cells (Vero) to the sum of the IC50 values of the cancerous cells (HT29, HeLa, and C6) and given in Table 1 . According to these information, the specificities of these compounds are not ideal because of poor selectivity. According to the Figure 1 , in cis-platin case, each coordination polymer poorly inhibited the proliferation of cells as compared to the control compounds (P < 0.05). However, the compounds C2 and C6 have showed relatively strong antiproliferative activity to the cells while the compounds C1 and C4 have done slightly low. A gradient obtained from the percent inhibition values of these coordination polymers can be seen for complexes in order of activity starting with the highest in activity: C2 > C6 > C4 > C1 > C3 ≈ C5 (Fig. 2) .
Figure 2. Effects of C1-C6
on the proliferation of cell lines. Percent inhibition was reported as mean values ± SEM of three independent assays (P < 0.05).
The results of the cell proliferation assay have showed that the coordination compounds have less anti-proliferative effect than that of cis-platin (Fig. 2) on the cell lines indicating that their anticancer potential should be improved further. 
Cytotoxic activity of the complexes on HT29, HeLa, C6 and Vero cells
The results obtained for the LDH assay are expressed in terms of percent cytotoxicity values and presented in Figure 3 . Findings showed that the test compounds possess approximately percent nonselective toxicity values from 40% to 85% against the cells investigated. These changes observed as rounding up, shrinking, and detaching from the well surface indicate that the cells were undergoing apoptosis which is a necessity for anticancer agents (Fig. 4) [20, 21] . The findings indicate that these morphological alterations are unlike necrotic situations which are usually characterized by cell swelling and eventual cell lysis. These results were somewhat similar with those of the previous studies by Korkmaz et al. [4] , Aydın et al., [2, 6] .
Thus, based on the observations in the literature, the appearance of cell lines treated with test compounds has indicated the anti-proliferative but high cytotoxic effect of these complexes clearly. Table 2 . With the increase in CT-DNA concentration resulted in hyperchromic effect, a strong interaction between these complexes and DNA can be explained. This hyperchromic effect on the spectra of the complex-DNA adduct might be indication of the groove binding. The interaction of these complexes with BSA can be determined via comparison of UV-Visible absorption spectra of the free metal complex and the complex-BSA adduct. The absorption spectra of the BSA solutions (0-100 μM) in the absence and presence of the complexes (25 μM) are shown in Figure 5B . The complexes have caused an increase in the absorbance of BSA and exhibited a blue shift indicating the Van der Waals interaction or hydrogen bonds through interaction with BSA. Isosbestic points near 265 -266 nm were observed for the C3, C5, and C6 compounds (Fig. 5B ). After KpnI and BamHI digestion of pTOLT plasmid DNA (patented plasmid vector, US 7348408 B2), digestion products were identified by two DNA bands in the absence of the complexes (Lane 7), whereas in the presence of the C1, C3 and C5 compounds have produced three bands (Lanes 2, 4, and 6) and the C2, C4 and C6 compounds have displayed four bands of DNA fragments seen near the well at the top of the lanes (Lanes 1, 3, and 5) (Fig. 6 ). In the presence of the complexes, DNA digestion was incomplete and new bands were observed. Treatment of KpnI and BamHI with the complexes inhibits partly the restriction endonucleases activity of these enzymes, and therefore more bands were seen on the gel. The results indicated that the complexes probably bound to pTOLT plasmid DNA or to these enzymes, and thus this situation has resulted in inhibition of KpnI and BamHI enzyme activity to a certain degree. against all cancer cells tested. However, in a preliminary in vitro study, these metal complexes appear to be nonselective against HT29, HeLa, C6 and Vero cells. These preliminary results are important because they indicate that these complexes have affected normal Vero cells. For these reasons, we believe that these complexes need to be developed by making a more rational design. Therefore, they may be a future replacement to the chemotherapeutic drugs in the clinical usage. As a conclusion, it seems substantial to continue to improve these chemical complex compounds to further help the problem of cancer.
DNA
